Extract

The purpose of this clinical research study is to determine the safety and effectiveness of an experimental drug called rilonacept in subjects with gout who are on urate-lowering therapy. Subjects will participate in this study for approximately 20 weeks. Rilonacept is being studied for use in preventing gout flares in subjects on urate-lowering therapy.

Inclusion criteria

• Gout

Country

• Germany
• India
• Indonesia
• South Africa
• Taiwan, Province of China
• United States

Links

• ictrp
• nct